Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.
King BF
,
Dacquet C
,
Ziganshin AU
,
Weetman DF
,
Burnstock G
,
Vanhoutte PM
,
Spedding M
.
???displayArticle.abstract???
1. 2,2'-Pyridylisatogen tosylate (PIT) has been reported to be an irreversible antagonist of responses to adenosine 5'-triphosphate (ATP) at metabotropic purinoceptors (of the P2Y family) in some smooth muscles. When a recombinant P2Y1 purinoceptor (derived from chick brain) is expressed in Xenopus oocytes, ATP and 2-methylthioATP (2-MeSATP) evoke calcium-activated chloride currents (ICl,Ca) in a concentration-dependent manner. The effects of PIT on these agonist responses were examined at this cloned P2Y purinoceptor. 2. PIT (0.1-100 microM) failed to stimulate P2Y1 purinoceptors directly but, over a narrow concentration range (0.1-3 microM), caused a time-dependent potentiation (2-5 fold) of responses to ATP. The potentiation of ATP-responses by PIT was not caused by inhibition of oocyte ecto-ATPase. At high concentrations (3-100 microM), PIT irreversibly inhibited responses to ATP with a IC50 value of 13 +/- 9 microM (pKB = 4.88 +/- 0.22; n = 3). PIT failed to potentiate inward currents evoked by 2-MeSATP and only inhibited the responses to this agonist in an irreversible manner. 3. Known P2 purinoceptor antagonists were tested for their ability to potentiate ATP-responses at the chick P2Y1 purinoceptor. Suramin (IC50 = 230 +/- 80 nM; n = 5) and Reactive blue-2 (IC50 = 580 +/- 130 nM; n = 6) reversibly inhibited but did not potentiate ATP-responses. Coomassie brilliant blue-G (0.1-3 microM) potentiated ATP-responses in three experiments, while higher concentrations (3-100 microM) irreversibly inhibited ATP-responses. The results indicated that potentiation and receptor antagonism were dissociable and not a feature common to all known P2 purinoceptor antagonists. 4. In radioligand binding assays, PIT showed a low affinity (pKi < 5) for a range of membrane receptors, including: alpha 1, alpha 2-adrenoceptors, 5-HT1A, 5-HT1B, 5-HT2, 5-HT3, D1, D2, muscarinic, central benzodiazepine, H1, mu-opioid, dihydropyridine and batrachotoxin receptors. PIT showed some affinity (pKi = 5.3) for an adenosine (A1) receptor. 5. In guinea-pig isolated taenia caeci, PIT (12.5-50 microM) irreversibly antagonized relaxations to ATP (3-1000 microM); PIT also directly relaxed the smooth muscle and histamine was used to restore tone. Relaxations to nicotine (10-100 microM), evoked by stimulating intrinsic NANC nerves of taenia caeci preparations in the presence of hyoscine (0.3 microM) and guanethidine (17 microM), were not affected by PIT (50 microM, for 25-60 min). 6. These experiments indicate that PIT causes an irreversible antagonism of ATP receptors but, for recombinant chick P2Y1 purinoceptors, this effect is preceded by potentiation of ATP agonism. The initial potentiation by PIT (and by Coomassie brilliant blue-G) of ATP-responses raises the possibility of designing a new class of modulatory drugs to enhance purinergic transmission at metabotropic purinoceptors.
Abbracchio,
Purinoceptors: are there families of P2X and P2Y purinoceptors?
1994, Pubmed
Abbracchio,
Purinoceptors: are there families of P2X and P2Y purinoceptors?
1994,
Pubmed
Barnard,
G protein-coupled receptors for ATP and other nucleotides: a new receptor family.
1994,
Pubmed
Boarder,
G protein-coupled P2 purinoceptors: from molecular biology to functional responses.
1995,
Pubmed
Brown,
3H-batrachotoxinin-A benzoate binding to voltage-sensitive sodium channels: inhibition by the channel blockers tetrodotoxin and saxitoxin.
1986,
Pubmed
Burnstock,
Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut.
1970,
Pubmed
Burnstock,
Studies on the stereoselectivity of the P2-purinoceptor.
1983,
Pubmed
Burnstock,
Is there a basis for distinguishing two types of P2-purinoceptor?
1985,
Pubmed
Cheng,
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
1973,
Pubmed
Dalziel,
Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization.
1994,
Pubmed
Dean,
Contribution of adrenergic and "purinergic" neurotransmission to contraction in rabbit detrusor.
1978,
Pubmed
Erb,
Site-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity.
1995,
Pubmed
Filtz,
Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
1994,
Pubmed
Foster,
Anatagonism of the inhibitory effects of adenosine 5'-triphosphate on the isolated taenia of the guinea-pig caecum: structure-activity relationships within a series of isatogen derivatives.
1978,
Pubmed
Gibson,
The effects of vasoactive intestinal polypeptide and of adenosine 5'-triphosphate on the isolated anococcygeus muscle of the mouse.
1982,
Pubmed
Goll,
Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation.
1983,
Pubmed
Hall,
[3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
1985,
Pubmed
Hess,
Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
1986,
Pubmed
Hill,
Histamine H1-receptors in the brain of the guinea-pig and the rat: differences in ligand binding properties and regional distribution.
1980,
Pubmed
Hillaire-Buys,
Dual regulation of pancreatic vascular tone by P2X and P2Y purinoceptor subtypes.
1991,
Pubmed
Hoyer,
Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.
1985,
Pubmed
Hu,
Interaction of dihydropyridine calcium channel agonists and antagonists with adenosine receptors.
1987,
Pubmed
Kazić,
Influence of pyridylisatogen tosylate on contractions produced by ATP and by purinergic stimulation in the terminal ileum of the guinea-pig.
1977,
Pubmed
Köhler,
Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
1985,
Pubmed
Leysen,
[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.
1982,
Pubmed
MCEWEN,
The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain.
1956,
Pubmed
Möhler,
Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels.
1981,
Pubmed
Moritoki,
Possible involvement of prostaglandins in the action of ATP on guinea-pig uterus.
1979,
Pubmed
Nelson,
[3H]-BRL 43694 (Granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranes.
1989,
Pubmed
Rattan,
Evidence against purinergic inhibitory nerves in the vagal pathway to the opossum lower esophageal sphincter.
1980,
Pubmed
Renouard,
Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
1994,
Pubmed
Rikimaru,
Effects of imidazole and phentolamine on the relaxant responses of guinea-pig taenia coli to transmural stimulation and to adenosine triphosphate.
1971,
Pubmed
Roskoski,
Degradation of rat brain cholinergic muscarinic receptors in vitro: enhancement by agonists and inhibition by antagonists.
1985,
Pubmed
Satchell,
Potentiation of the effects of exogenously applied ATP and purinergic nerve stimulation on the guinea-pig taenia coli by dipyridamole and hexobendine.
1972,
Pubmed
Satchell,
Antagonism of the effects of purinergic nerve stimulation and exogenously applied ATP on the guinea-pig taenia coli by 2-substituted imidazolines and related compounds.
1973,
Pubmed
Sharif,
Discrete mapping of brain Mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors.
1989,
Pubmed
Simon,
Characterisation of a recombinant P2Y purinoceptor.
1995,
Pubmed
,
Xenbase
Small,
The effects of 2-2'-pyridylisatogen tosylate on the electrical activity of smooth muscle of the isolated taenia caeci of the guinea-pig [proceedings].
1978,
Pubmed
Soltoff,
Coomassie Brilliant Blue G is a more potent antagonist of P2 purinergic responses than Reactive Blue 2 (Cibacron Blue 3GA) in rat parotid acinar cells.
1989,
Pubmed
Spedding,
The mechanism of the relaxant effect of 2-2'-pyridylisatogen on the isolated taenia of the guinea-pig caecum.
1978,
Pubmed
Spedding,
The problems associated with the use of 2,2'-pyridylisatogen tosylate in evaluating the allegedly purinergic innervation of peripheral organs.
1978,
Pubmed
Spedding,
Antagonism of adenosine 5'-triphosphate-induced relaxation by 2-2'-pyridylisatogen in the taenia of guinea-pig caecum.
1975,
Pubmed
Spedding,
Identification of separate receptors for adenosine and adenosine 5'-triphosphate in causing relaxations of the isolated taenia of the guinea-pig caecum.
1976,
Pubmed
Su,
Purinergic inhibition of adrenergic transmission in rabbit blood vessels.
1978,
Pubmed
Tokuyama,
Cloning of rat and mouse P2Y purinoceptors.
1995,
Pubmed
,
Xenbase
VAN ROSSUM,
Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters.
1963,
Pubmed
Webb,
Cloning and functional expression of a brain G-protein-coupled ATP receptor.
1993,
Pubmed
,
Xenbase
Ziganshin,
Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown.
1995,
Pubmed
,
Xenbase